Metabolic fate of KRN8601: Plasma level, distribution and excretion of 125I-KRN8601 after repeated intravenous administration to rats.
スポンサーリンク
概要
- 論文の詳細を見る
Plasma level, distribution and excretion of <SUP>125</SUP>I-KRN8601 after sixth cosecutive daily intravenous administrations were examined in male rats.<BR>After sixth intravenous administration of <SUP>125</SUP>I-KRN8601 at the dose of 5μg/kg/day, the plasma levels of total and trichloroacetic acid precipitable radioactivity declined more slowly than those after a single administration, whereas no difference in the plasma level profile of immunoreactive radioactivity was seen when compared to that after a single administration.<BR>Except the thyroid which showed the extremely high level of radioactivity, the concentration of radioactivity in each organ decreased with time after repeated administration, and no accumulation of <SUP>125</SUP>I-KRN8601 in any particular organs or tissues was observed.<BR>Excretion of radioactivity in urine and feces was almost constant, i.e. over 70% and 4 ?? 6 % of each administered dose, respectively, during repeated administration. Finally, more than 90% or the administered radioactivity excreted in the urine and feces within 96 hours after the last dosing.<BR>All the radioactivity excreted in urine appeared to be low molecular weight compounds.
- 日本薬物動態学会の論文
日本薬物動態学会 | 論文
- COMPETITIVE DISPLACEMENT OF SERUM PROTEIN BINDING TO REGULATE PHARMACOKINETICS OF A CEREBRAL BLOOD FLOW RADIOPHARMACEUTICAL
- Studies on the Metabolic Fate of Felodipine. (IV). Identification of New Metabolites of Felodipine in Rat.
- Metabolic Fate of Pergolide Mesylate. (2): Absorption, Distribution, Excretion of 14C-Pergolide Mesylate in Rats after Repeated Administration.
- Studies on the Metabolic Fate of 3H-TJN-101. (III): Absorption, Distribution and Excretion after Multiple Oral Administration to Rats.
- Studies on the Pharmacokinetics of Perindopril Erbumine in Rats. (1): Plasma Level Profile, Distribution, Metabolism and Excretion after Single Oral Administration.